top of page
Innovative Healthcare, Trusted Solutions

Explore our range of high-quality medical and wellness products designed to support healthier lives. From preventive care to advanced treatments, Central West Medicale Inc. delivers trusted solutions for patients, professionals, and communities across the Philippines.

Norepinephrine Norecent box with ampule, prescription label, product shot, Central West Medical.

Norecent (Norepinephrine)

NOREPINEPHRINE

1 mg/mL (4mg/4mL) Solution for Injection (I.V.)

1 mg/mL (10mg/10mL) Solution for Injection (I.V.)

Anti-arrhythmic

SUMMARY

Norepinephrine is a sympathomimetic used in the control of blood pressure during various hypotensive states and as an adjunct treatment during cardiac arrest.

 

INDICATION

Mainly used to treat patients in vasodilatory shock states such as septic shock and neurogenic shock and has shown a survival benefit over dopamine. Also used as a vasopressor medication for patients with critical hypotension.

 

PHARMACOKINETICS

Absorption : Norepinephrine is rapidly administered via IV.

Distribution : Widely distributed in body tissues; crosses the blood-brain barrier minimally.

Metabolism : Primarily metabolized by catechol-O-methyltransferase and monoamine oxidase.

Elimination: Metabolites excreted in urine.

Protein Binding: Approximately 50% bound to plasma proteins.

Half Life: The half-life of Norepinephrine is approximately 2-3 minutes.

 

MECHANISM OF ACTION

Acts as a potent alpha-adrenergic agonist, causing vasoconstriction and increasing systemic vascular resistance, with some beta-1 adrenergic activity that enhances cardiac output.

 

PHARMACODYNAMICS

Increases blood pressure and improves perfusion to vital organs by enhancing myocardial contractility and systemic vascular resistance.

 

CAUTIONS

Monitor for extravasation, hypertension, and arrhythmias; use with caution in patients with peripheral vascular disease.

 

METHOD OF ADMINISTRATION

Administered intravenously via continuous infusion.

 

OVERDOSE AND TREATMENT

May cause severe hypertension and bradycardia; treatment includes discontinuation and symptomatic management.

 

IN PREGNANCY AND LACTATION

Use only if clearly needed; potential risks to the fetus should be considered.

 

TOXICITY

Excessive vasoconstriction may lead to ischemia of tissues.

 

DOSAGE AND ADMINISTRATION

Initial infusion rate is typically 0.05 to 0.5 mcg/kg/min, titrated to achieve desired blood pressure.

 

WHY NORECENT?

  • Norepinephrine provides flexibility in dosing for patients requiring higher concentrations.
  • High quality at lesser cost

 

 

Related Products

bottom of page